Optimising stable retroviral transduction of primary human synovial fibroblasts

Journal of Virological Methods

Volumn 137, Issue 1, 2006, Pages 95-102

  Paya, Monica ^a   Segovia, Jose C ^b   Santiago, Begoña ^a   Galindo, Maria ^a   del Rio, Paola ^b   Pablos, Jose L ^a   Ramírez, Juan C ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CIEMAT   (Spain)

Author keywords

Fibroblast like synoviocyte; Gene therapy; Retrovirus; Rheumatoid arthritis

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ARTICLE; ASSAY; CELL FUNCTION; CELL ISOLATION; CELL LINE; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG TARGETING; EX VIVO STUDY; EXPERIMENTAL STUDY; EXPRESSION VECTOR; FIBROBLAST; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPEAT PROCEDURE; REPRODUCIBILITY; REST; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FIBROBLASTS; GENE THERAPY; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; SYNOVIAL FLUID; TRANSDUCTION, GENETIC;

EID: 33746881096     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.06.005     Document Type: Article

References (41)

1. Bahnson A.B., Dunigan J.T., Baysal B.E., Mohney T., Atchison R.W., Nimgaonkar M.T., Ball E.D., and Barranger J.A. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods 54 2-3 (1995) 131-143
2. Baum C., Hegewisch-Becker S., Eckert H.G., Stocking C., and Ostertag W. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69 12 (1995) 7541-7547
3. Bueren J.A., Guenechea G., Casado J.A., Lamana M.L., and Segovia J.C. Genetic modification of hematopoietic stem cells: recent advances in the gene therapy of inherited diseases. Arch. Med. Res. 34 6 (2003) 589-599
4. Chappell S.A., Edelman G.M., and Mauro V.P. A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc. Natl. Acad. Sci. U.S.A. 97 4 (2000) 1536-1541
5. Chernajovsky Y., Adams G., Podhajcer O.L., Mueller G.M., Robbins P.D., and Feldmann M. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther. 2 10 (1995) 731-735
6. Chernajovsky Y., Gould D.J., and Podhajcer O.L. Gene therapy for autoimmune diseases: quo vadis?. Nat. Rev. Immunol. 4 10 (2004) 800-811
7. Chernajovsky Y., Vessillier S., Adams G., Gofur Y., Subang M.C., Annenkov A., Favorov P., Daly G., and Gould D. Development of new molecules, vectors and cells for therapy of arthritis. Joint Bone Spine 70 6 (2003) 474-476
8. Chuck A.S., and Palsson B.O. Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum. Gene Ther. 7 6 (1996) 743-750
9. Coelen R.J., Jose D.G., and May J.T. The effect of hexadimethrine bromide (polybrene) on the infection of the primate retroviruses SSV 1/SSAV 1 and BaEV. Arch. Virol. 75 4 (1983) 307-311
10. Dasuri K., Antonovici M., Chen K., Wong K., Standing K., Ens W., El-Gabalawy H., and Wilkins J.A. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. 6 2 (2004) R161-R168
11. Del Vecchio M.A., Georgescu H.I., McCormack J.E., Robbins P.D., and Evans C.H. Approaches to enhancing the retroviral transduction of human synoviocytes. Arthritis Res. 3 4 (2001) 259-263
12. Edwards J.C. Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res. 2 5 (2000) 344-347
13. Evans C.H., Robbins P.D., Ghivizzani S.C., Wasko M.C., Tomaino M.M., Kang R., Muzzonigro T.A., Vogt M., Elder E.M., Whiteside T.L., Watkins S.C., and Herndon J.H. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc. Natl. Acad. Sci. U.S.A. 102 24 (2005) 8698-8703
14. Fehse B., Kustikova O.S., Bubenheim M., and Baum C. Pois(s)on-it's a question of dose. Gene Ther. 11 11 (2004) 879-881
15. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 6937 (2003) 356-361
16. Forestell S.P., Bohnlein E., and Rigg R.J. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 2 10 (1995) 723-730
17. Ghosh S.S., Takahashi M., Thummala N.R., Parashar B., Chowdhury N.R., and Chowdhury J.R. Liver-directed gene therapy: promises, problems and prospects at the turn of the century. J. Hepatol. 32 Suppl. 1 (2000) 238-252
18. Gould D.J., and Favorov P. Vectors for the treatment of autoimmune disease. Gene Ther. 10 10 (2003) 912-927
19. Hanenberg H., Hashino K., Konishi H., Hock R.A., Kato I., and Williams D.A. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum. Gene Ther. 8 18 (1997) 2193-2206
20. Hirschmann F., Verhoeyen E., Wirth D., Bauwens S., Hauser H., and Rudert M. Vital marking of articular chondrocytes by retroviral infection using green fluorescence protein. Osteoarthritis Cartilage 10 2 (2002) 109-118
21. Kuhlcke K., Fehse B., Schilz A., Loges S., Lindemann C., Ayuk F., Lehmann F., Stute N., Fauser A.A., Zander A.R., and Eckert H.G. Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. Mol. Ther. 5 4 (2002) 473-478
22. Lamana M.L., Segovia J.C., Guenechea G., and Bueren J.A. Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells. J. Gene Med. 3 1 (2001) 32-41
23. Le Doux J.M., Morgan J.R., Snow R.G., and Yarmush M.L. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J. Virol. 70 9 (1996) 6468-6473
24. Li Z.X., Schade U.M., Fehse B., Stockschlader M., Uhde A., Koch S., Goller B., Ruger R., Fehse N., and Zander A.R. High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes. Adv. Exp. Med. Biol. 451 (1998) 375-378
25. Lin Y.L., Noel D., Mettling C., Reant B., Clot J., Jorgensen C., and Corbeau P. Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritis. Hum. Gene Ther. 15 6 (2004) 588-596
26. Merten O.W. State-of-the-art of the production of retroviral vectors. J. Gene Med. 6 Suppl. 1 (2004) S105-S124
27. Miller A.D., Garcia J.V., von Suhr N., Lynch C.M., Wilson C., and Eiden M.V. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65 5 (1991) 2220-2224
28. Muller-Ladner U., Kriegsmann J., Franklin B.N., Matsumoto S., Geiler T., Gay R.E., and Gay S. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149 5 (1996) 1607-1615
29. Nash K.L., and Lever A.M.L. Green fluorescent protein: green cells do not always indicate gene expression. Gene Ther. 11 (2004) 882-883
30. Olsen N.J., and Stein C.M. New drugs for rheumatoid arthritis. N. Engl. J. Med. 350 21 (2004) 2167-2179
31. Pages J.C., and Bru T. Toolbox for retrovectorologists. J. Gene Med. 6 Suppl. 1 (2004) S67-S82
32. Relander T., Brun A., Hawley R.G., Karlsson S., and Richter J. Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium. J. Gene Med. 3 3 (2001) 207-218
33. Robbins P.D., Evans C.H., and Chernajovsky Y. Gene therapy for arthritis. Gene Ther. 10 10 (2003) 902-911
34. Rudoll T., Phillips K., Lee S.W., Hull S., Gaspar O., Sucgang N., Gilboa E., and Smith C. High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes. Gene Ther. 3 8 (1996) 695-705
35. Scaife S., Brown R., Kellie S., Filer A., Martin S., Thomas A.M., Bradfield P.F., Amft N., Salmon M., and Buckley C.D. Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display. Rheumatology (Oxford) 43 11 (2004) 1346-1352
36. Somia N., and Verma I.M. Gene therapy: trials and tribulations. Nat. Rev. Genet. 1 2 (2000) 91-99
37. Towers G.J., Stockholm D., Labrousse-Najburg V., Carlier F., Danos O., and Pages J.C. One step screening of retroviral producer clones by real time quantitative PCR. J. Gene Med. 1 5 (1999) 352-359
38. Verma I.M., and Somia N. Gene therapy-promises, problems and prospects. Nature 389 6648 (1997) 239-242
39. Yamanishi Y., and Firestein G.S. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum. Dis. Clin. North Am. 27 2 (2001) 355-371
40. Yang J., Friedman M.S., Bian H., Crofford L.J., Roessler B., and McDonagh K.T. Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatant. Arthritis Res. 4 3 (2002) 215-219
41. Zimmermann T., Kunisch E., Pfeiffer R., Hirth A., Stahl H.D., Sack U., Laube A., Liesaus E., Roth A., Palombo-Kinne E., Emmrich F., and Kinne R.W. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture-primary culture cells markedly differ from fourth-passage cells. Arthritis Res. 3 1 (2001) 72-76